Abstract
Buccal delivery of saquinavir has the advantage to bypass the gastrointestinal enzymatic degradation and the hepatic first-pass metabolism. Saquinavir has a pH-dependent solubility and is poorly soluble in human saliva at the physiological pH. Decreasing microenvironmental pH (pHM) in saliva may increase saquinavir release from buccal formulations. The present study aimed to investigate the effects of organic acids on the pHM, saquinavir release in vitro and the solid-state form of saquinavir. An UV/Vis imaging method was used to measure pHM. After 5min of swelling of the buccal films containing malic acid, pHM was reduced from 6.8 to 5.4. The films containing malic acid were more efficient in maintaining low pHM than films containing citric acid and succinic acid. Addition of organic acids in the buccal films resulted in a faster drug release than films without acids due to the reduced pHM. However, the enhancement of saquinavir release was limited by the fast release of organic acids. Addition of malic acid and citric acid suppressed the crystallization of saquinavir during 3months storage at the elevated temperature (40°C) and humidity (RH 75%) respectively. These results suggest that pHM modifying film is a potential formulation strategy for buccal delivery of saquinavir.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
